0001593968-24-000842.txt : 20240611
0001593968-24-000842.hdr.sgml : 20240611
20240611161019
ACCESSION NUMBER: 0001593968-24-000842
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240605
FILED AS OF DATE: 20240611
DATE AS OF CHANGE: 20240611
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Yoshiyama Annie
CENTRAL INDEX KEY: 0001835208
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38693
FILM NUMBER: 241035853
MAIL ADDRESS:
STREET 1: 7000 SHORELINE COURT
STREET 2: SUITE 201
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allogene Therapeutics, Inc.
CENTRAL INDEX KEY: 0001737287
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 823562771
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 457-2700
MAIL ADDRESS:
STREET 1: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
3
1
primary_01.xml
PRIMARY DOCUMENT
X0206
3
2024-06-05
0
0001737287
Allogene Therapeutics, Inc.
ALLO
0001835208
Yoshiyama Annie
210 EAST GRAND AVE
SOUTH SAN FRANCISCO
94080
true
SVP, Finance
Common Stock
101758
D
Stock Option (Right to buy)
3.98
2034-04-08
Common Stock
348708
D
Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting, 1/4th of the RSUs will vest on April 20th, 2025 and the remainder will vest annually thereafter.
25% of the shares subject to the stock option shall vest on April 8, 2025, and the remaining shares shall vest in 36 equal monthly installments thereafter.
/s/Annie Yoshiyama
2024-06-11